Prosecution Insights
Last updated: April 19, 2026

Kramer & Amado, P.C.

19 pending office actions • 17 clients

Portfolio Summary

19
Total Pending OAs
8
Final Rejections
11
Non-Final OAs

Client Portfolio (17 clients)

Client (Assignee)Pending OAs
Navin Saxena Research And Technology Private Limited 2
West Virginia University 2
Analytica Legalis, Inc. 1
Fundacion Profesor Novoa Santos 1
Fertis India Pvt. Ltd. 1
BDR LIFESCIENCES PRIVATE LIMITED 1
BDR LIFESCIENCES PRIVATE LIMITED 1
West Virginia University 1
Jho Intellectual Property Holdings, LLC 1
X-Energy, LLC 1
Garware Technical Fibres Ltd. 1
Olene Life Sciences Private Limited 1
Fermenta Biotech Limited 1
Fer-Pal Construction, Ltd. 1
Aglaris Ltd. 1
West Virginia University 1
Gongwin Biopharm Co., Ltd. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18830193 Untitled Analytica Legalis, Inc. GILKEY, CARRIE STRODER 3626 Non-Final OA
18708136 ABSORBENT ELEMENT HAVING A MOISTURE BARRIER Fundacion Profesor Novoa Santos WRUBLESKI, MATTHEW JAMES 3781 Non-Final OA May 07, 2024
18547025 AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH Navin Saxena Research And Technology Private Limited PEEBLES, KATHERINE 1617 Final Rejection Aug 18, 2023
18547044 NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF Navin Saxena Research And Technology Private Limited BAZARGANI, ARYA AHMADI 1613 Non-Final OA Aug 18, 2023
18256295 BIO PESTICIDAL COMPOSITION CONTAINS NOVEL NONANOATE ESTERS OF SUGARS AND SUGAR ALCOHOLS TO CONTROL LEPIDOPTERA, HEMIPTERA AND THYSANOPTERA INSECTS Fertis India Pvt. Ltd. GONZALEZ, LUISALBERTO 1624 Non-Final OA Jun 07, 2023
18249344 ORAL FORMULATIONS OF NINTEDANIB AND METHOD OF MANUFACTURING THEREOF BDR LIFESCIENCES PRIVATE LIMITED MOU, LIYUAN 1628 Non-Final OA Apr 17, 2023
18040868 AN IMPROVED HIGHLY EFFICIENT PROCESS FOR THE PREPARATION OF NINTEDANIB AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF BDR LIFESCIENCES PRIVATE LIMITED SEAMAN, D MARGARET M 1625 Non-Final OA Feb 07, 2023
18054285 Compositions Comprising Human Skin Fibroblasts and Amyloid Beta Peptide West Virginia University MACFARLANE, STACEY NEE 1675 Final Rejection Nov 10, 2022
18049089 ELECTROLYTE SPORTS DRINK FORMULATION FOR ENHANCING HYDRATION AND REPLENISHMENT OF NUTRIENTS Jho Intellectual Property Holdings, LLC MORENO, LARK JULIA 1793 Non-Final OA Oct 24, 2022
17845385 SYSTEM AND METHOD FOR MAKING NUCLEAR FUEL ELEMENTS WITH A CONTROLLED NUMBER OF NUCLEAR PARTICLES X-Energy, LLC WASIL, DANIEL D 3646 Final Rejection Jun 21, 2022
17826919 FLEXIBLE ROPE NET GABION Garware Technical Fibres Ltd. FIORELLO, BENJAMIN F 3678 Final Rejection May 27, 2022
17554636 COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF Olene Life Sciences Private Limited BOECKELMAN, JACOB A 1655 Non-Final OA Dec 17, 2021
17609935 METHOD FOR SYNTHESIZING 25-OH CHOLESTEROL/CALCIFEDIOL FROM PHYTOSTEROL Fermenta Biotech Limited MOORE, SUSANNA 1624 Final Rejection Nov 09, 2021
17507961 ROAD PLATE MOVING SYSTEM AND METHOD Fer-Pal Construction, Ltd. ADDIE, RAYMOND W 3671 Final Rejection Oct 22, 2021
17048485 CELL SEPARATION CHAMBER AND CELL SEPARATION SYSTEM AND METHOD Aglaris Ltd. LEPAGE, JONATHAN EVERETT 1796 Non-Final OA Oct 16, 2020
17066961 FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE West Virginia University MACFARLANE, STACEY NEE 1675 Final Rejection Oct 09, 2020
16456887 BENZENESULFONAMIDE DERIVATIVES AND METHOD FOR TREATING CANCER Gongwin Biopharm Co., Ltd. DAVIS, BRIAN J 1614 Non-Final OA Jun 28, 2019
15107152 CONVERGENCE OF AGGREGATION RATE WITH VALIDATED PERIPHERAL DIAGNOSTIC FOR ALZHEIMER'S DISEASE West Virginia University NGUYEN, NGHI V 1653 Final Rejection Jun 22, 2016
14346822 STIMULUS-ELICITED GENOMIC PROFILE MARKERS OF A NEURODEGENERATIVE CONDITION West Virginia University FONTAINHAS, AURORA M 1675 Non-Final OA Mar 24, 2014

Managing Kramer & Amado, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month